Gentofte, Denmark

Thomas Dock Steenstrup

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Thomas Dock Steenstrup: Innovator in Factor VIII Polypeptide Research

Introduction

Thomas Dock Steenstrup is a notable inventor based in Gentofte, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of Factor VIII polypeptides. With a total of six patents to his name, Steenstrup's work has advanced the understanding and production of essential therapeutic proteins.

Latest Patents

One of Steenstrup's latest patents is focused on the production of a Factor VIII polypeptide in cell cultures. This invention outlines a method that involves culturing a mammalian cell that expresses the Factor VIII polypeptide under specific conditions. These conditions include using a cell culture medium that contains a C2-domain ligand, followed by isolating the expressed Factor VIII polypeptide from the mammalian cell using suitable means. Another significant patent involves conjugated Factor VIII molecules, which are B-domain truncated Factor VIII molecules with a modified circulatory half-life. This invention details the covalent conjugation of these molecules with a hydrophilic polymer, along with methods for obtaining such molecules and their potential uses.

Career Highlights

Throughout his career, Thomas Dock Steenstrup has worked with prominent companies in the healthcare sector, including Novo Nordisk Healthcare AG and Novo Nordisk A/S. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of biotechnology.

Collaborations

Steenstrup has collaborated with several professionals in his field, including Peder Lisby Norby and Gert Bolt. These collaborations have further enriched his research and innovation efforts.

Conclusion

Thomas Dock Steenstrup is a distinguished inventor whose work in Factor VIII polypeptide research has made a significant impact in biotechnology. His innovative patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…